Clinical Trials in Guangdong, China
Locations / Guangdong, China
Delta Trials lists 194 clinical trials conducted in Guangdong, China, making it a notable site of clinical research activity. These trials addressing 241 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 16 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Guangdong research landscape.
194
Total Trials
241
Conditions
16
Terminated since 2020
Browse by condition (241 total)
- Coronary artery disease 5 trialsAll Coronary artery disease trials
- Breast cancer 5 trialsAll Breast cancer trials
- Non-small cell lung cancer 5 trialsAll Non-small cell lung cancer trials
- Gastric cancer 4 trialsAll Gastric cancer trials
- Pulmonary embolism 3 trialsAll Pulmonary embolism trials
- Colorectal cancer 3 trialsAll Colorectal cancer trials
- Psoriasis 3 trialsAll Psoriasis trials
- Nsclc 2 trialsAll Nsclc trials
- Chronic myeloid leukemia 2 trialsAll Chronic myeloid leukemia trials
- Asthma 2 trialsAll Asthma trials
- Acute ischemic stroke 2 trialsAll Acute ischemic stroke trials
- Deep venous thrombosis 2 trialsAll Deep venous thrombosis trials
- Chronic hcv infection 2 trialsAll Chronic hcv infection trials
- All Chronic obstructive pulmonary disease trials
- Advanced solid tumors 2 trialsAll Advanced solid tumors trials
- Ovarian cancer 2 trialsAll Ovarian cancer trials
- Neoplasms 2 trialsAll Neoplasms trials
- Advanced malignant tumors 2 trialsAll Advanced malignant tumors trials
- Healthy 2 trialsAll Healthy trials
- Nasopharyngeal carcinoma (npc) 2 trialsAll Nasopharyngeal carcinoma (npc) trials